{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:43:39Z","timestamp":1778100219588,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"am","delay-in-days":280,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["UG3\/UH3 NS134920"],"award-info":[{"award-number":["UG3\/UH3 NS134920"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007472","name":"University of Kentucky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cbi.2025.111552","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T02:40:26Z","timestamp":1746499226000},"page":"111552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Treatment of acute organophosphate poisoning by using a cocaine hydrolase engineered from human butyrylcholinesterase"],"prefix":"10.1016","volume":"416","author":[{"given":"Johnathan E.","family":"LeSaint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shurong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nellore Bhanu","family":"Chandar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annet","family":"Kyomuhangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4128-7269","authenticated-orcid":false,"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111552_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109996","article-title":"Strategies for developing a recombinant butyrylcholinesterase medical countermeasure for Organophosphorus poisoning","volume":"363","author":"Allard","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111552_bib2","volume":"vol. 11","author":"Tadesse","year":"2023"},{"key":"10.1016\/j.cbi.2025.111552_bib3","series-title":"Preventing suicide by phasing out highly hazardous pesticides","year":"2024"},{"issue":"23","key":"10.1016\/j.cbi.2025.111552_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.9734\/ijtdh\/2023\/v44i231503","article-title":"Influence of psycho social issues on intentional organophosphates self-poisoning among persons aged 15-30 Years in kericho county, Kenya","volume":"44","author":"Sigey","year":"2023","journal-title":"International Journal of TROPICAL DISEASE & Health"},{"key":"10.1016\/j.cbi.2025.111552_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.abb.2018.08.006","article-title":"Decarbamoylation of acetylcholinesterases is markedly slowed as carbamoyl groups increase in size","volume":"655","author":"Venkatasubban","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.cbi.2025.111552_bib6","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00204-020-02797-0","article-title":"Organophosphorus compounds and oximes: a critical review","volume":"94","author":"Worek","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.cbi.2025.111552_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101007","article-title":"Covalent inhibition of hAChE by organophosphates causes homodimer dissociation through long-range allosteric effects","volume":"297","author":"Blumenthal","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111552_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2018.07.006","article-title":"Catalytic bioscavengers as countermeasures against organophosphate nerve agents","volume":"92","author":"Goldsmith","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111552_bib9","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/acs.biomac.0c00959","article-title":"Catalytic detoxification of organophosphorus nerve agents by butyrylcholinesterase-polymer-oxime bioscavengers","volume":"21","author":"Zhang","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.cbi.2025.111552_bib10","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/j.1742-4658.2012.08672.x","article-title":"Human butyrylcholinesterase produced in insect cells: huprine\u2010based affinity purification and crystal structure","volume":"279","author":"Brazzolotto","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2025.111552_bib11","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"47","key":"10.1016\/j.cbi.2025.111552_bib12","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1073\/pnas.1009021107","article-title":"Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents","volume":"107","author":"Geyer","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"34","key":"10.1016\/j.cbi.2025.111552_bib13","doi-asserted-by":"crossref","first-page":"13603","DOI":"10.1073\/pnas.0702756104","article-title":"Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning","volume":"104","author":"Huang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cbi.2025.111552_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12896-016-0302-9","article-title":"Plant expression of cocaine hydrolase-Fc fusion protein for treatment of cocaine abuse","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.cbi.2025.111552_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/biot.201300229","article-title":"Expression of human butyrylcholinesterase with an engineered glycosylation profile resembling the plasma-derived orthologue","volume":"9","author":"Schneider","year":"2014","journal-title":"Biotechnol. J."},{"issue":"4","key":"10.1016\/j.cbi.2025.111552_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13179","article-title":"Recovery of dopaminergic system after cocaine exposure and impact of a long-acting cocaine hydrolase","volume":"27","author":"Deng","year":"2022","journal-title":"Addict. Biol."},{"issue":"7","key":"10.1016\/j.cbi.2025.111552_bib17","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1021\/acs.bioconjchem.2c00210","article-title":"Development of a highly efficient long-acting cocaine hydrolase entity to accelerate cocaine metabolism","volume":"33","author":"Zheng","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.cbi.2025.111552_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108251","article-title":"Clinical potential of a rationally engineered enzyme for treatment of cocaine dependence: long-lasting blocking of the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine","volume":"176","author":"Zhang","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2025.111552_bib19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1073\/pnas.1517713113","article-title":"Long-acting cocaine hydrolase for addiction therapy","volume":"113","author":"Chen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cbi.2025.111552_bib20","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1038\/ncomms4457","article-title":"A highly efficient cocaine-detoxifying enzyme obtained by computational design","volume":"5","author":"Zheng","year":"2014","journal-title":"Nat. Commun."},{"issue":"36","key":"10.1016\/j.cbi.2025.111552_bib21","doi-asserted-by":"crossref","first-page":"12148","DOI":"10.1021\/ja803646t","article-title":"Most efficient cocaine hydrolase designed by virtual screening of transition states","volume":"130","author":"Zheng","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2025.111552_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/mol.108.049486","article-title":"Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity","volume":"75","author":"Gao","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111552_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/10550887.2014.969603","article-title":"A randomized, double-blind, placebo-controlled trial of RBP-8000 in cocaine abusers: pharmacokinetic profile of rbp-8000 and cocaine and effects of RBP-8000 on cocaine-induced physiological effects","volume":"33","author":"Nasser","year":"2014","journal-title":"J. Addict. Dis."},{"issue":"46","key":"10.1016\/j.cbi.2025.111552_bib24","doi-asserted-by":"crossref","first-page":"16656","DOI":"10.1073\/pnas.0507332102","article-title":"Computational redesign of human butyrylcholinesterase for anticocaine medication","volume":"102","author":"Pan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20133","key":"10.1016\/j.cbi.2025.111552_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cbi.2010.01.004","article-title":"Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine","volume":"187","author":"Yang","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111552_bib26","article-title":"Clinical potential of an enzyme-based novel therapy for cocaine overdose","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111552_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1208\/s12248-017-0167-4","article-title":"Effectiveness of a cocaine hydrolase for cocaine toxicity treatment in male and female rats","volume":"20","author":"Zheng","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.cbi.2025.111552_bib28","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1021\/bi1011628","article-title":"Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency","volume":"49","author":"Zheng","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2025.111552_bib29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/mol.110.068494","article-title":"Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine","volume":"79","author":"Xue","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111552_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1208\/s12248-020-00442-3","article-title":"Structure-based design and discovery of a long-acting cocaine hydrolase mutant with improved binding affinity to neonatal Fc receptor for treatment of cocaine abuse","volume":"22","author":"Zheng","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.cbi.2025.111552_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cbi.2019.04.012","article-title":"Development of a long-acting Fc-fused cocaine hydrolase with improved yield of protein expression","volume":"306","author":"Chen","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111552_bib32","unstructured":"https:\/\/en.wikipedia.org\/wiki\/Paraoxon."},{"key":"10.1016\/j.cbi.2025.111552_bib33","series-title":"In Insecticides - Basic and Other Applications","first-page":"79","article-title":"Development of a prophylactic butyrylcholinesterase bioscavenger to protect against insecticide toxicity using a homologous macaque model","author":"Rosenberg","year":"2012"},{"key":"10.1016\/j.cbi.2025.111552_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/BJ20130549","article-title":"Preparation and in vivo characterization of a cocaine hydrolase engineered from human butyrylcholinesterase for metabolizing cocaine","volume":"453","author":"Xue","year":"2013","journal-title":"Biochem. J."},{"issue":"22","key":"10.1016\/j.cbi.2025.111552_bib35","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"issue":"42","key":"10.1016\/j.cbi.2025.111552_bib36","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2025.111552_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.cbi.2025.111552_bib38","unstructured":"Schr\u00f6dinger Release 2021-4: Maestro 13.0, Schr\u00f6dinger, LLC, New York, NY, 2021-2024."},{"key":"10.1016\/j.cbi.2025.111552_bib39","series-title":"Gaussian 16, Revision A.03","first-page":"2016","author":"Frisch","year":"2016"},{"issue":"1","key":"10.1016\/j.cbi.2025.111552_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1747-0285.2005.00327.x","article-title":"Use of an induced fit receptor structure in virtual screening","volume":"67","author":"Sherman","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"issue":"2","key":"10.1016\/j.cbi.2025.111552_bib41","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111552_bib42","series-title":"AMBER 2020","author":"Case","year":"2020"},{"issue":"1","key":"10.1016\/j.cbi.2025.111552_bib43","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J. Chem. Theor. Comput."},{"issue":"9","key":"10.1016\/j.cbi.2025.111552_bib44","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"11","key":"10.1016\/j.cbi.2025.111552_bib45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/jcc.540161106","article-title":"Application of the multimolecule and multiconformational RESP methodology to biopolymers: charge derivation for DNA, RNA, and proteins","volume":"16","author":"Piotr Cieplak","year":"1995","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2025.111552_bib46","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"3","key":"10.1016\/j.cbi.2025.111552_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0006-2952(98)00035-5","article-title":"Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon","volume":"56","author":"Amitai","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111552_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108756","article-title":"Dimerization of human butyrylcholinesterase expressed in bacterium for development of a thermally stable bioscavenger of organophosphorus compounds","volume":"310","author":"Cai","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.cbi.2025.111552_bib49","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/toxsci\/kfj094","article-title":"Concentration-dependent kinetics of acetylcholinesterase inhibition by the organophosphate paraoxon","volume":"90","author":"Rosenfeld","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.cbi.2025.111552_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/BJ20141266","article-title":"Kinetic characterization of a cocaine hydrolase engineered from mouse butyrylcholinesterase","volume":"466","author":"Chen","year":"2015","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.cbi.2025.111552_bib51","article-title":"Gene transfer of mutant mouse cholinesterase provides high lifetime expression and reduced cocaine responses with no evident toxicity","volume":"8","author":"Geng","year":"2013","journal-title":"PLoS"},{"key":"10.1016\/j.cbi.2025.111552_bib52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jcph.450","article-title":"Pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and Multiple intramuscular injections in healthy subjects","volume":"55","author":"Cohen-Barak","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111552_bib53","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/JCP.0000000000000347","article-title":"Assessment of pharmacokinetic and pharmacodynamic interactions between albumin-fused mutated butyrylcholinesterase and intravenously administered cocaine in recreational cocaine users","volume":"35","author":"Shram","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cbi.2025.111552_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2016.05.019","article-title":"Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence","volume":"166","author":"Gilgun-Sherki","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"10.1016\/j.cbi.2025.111552_bib55","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/sj.npp.1301666","article-title":"A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats","volume":"33","author":"Brimijoin","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cbi.2025.111552_bib56","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/522S53a","article-title":"Quest for the quitting pill","volume":"522","author":"Willyard","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2025.111552_bib57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.drugalcdep.2018.01.033","article-title":"TV-1380 attenuates cocaine-induced changes in cardiodynamic parameters in monkeys and reduces the formation of cocaethylene","volume":"188","author":"Shemesh-Darvish","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.cbi.2025.111552_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61646-7","article-title":"In vitro and in vivo stability of a highly efficient long-acting cocaine hydrolase","volume":"14","author":"Shang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111552_bib59","first-page":"473","volume":"vol. 11","author":"Zhan","year":"2022"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:52:20Z","timestamp":1762113140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725001826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":59,"alternative-id":["S0009279725001826"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111552","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of acute organophosphate poisoning by using a cocaine hydrolase engineered from human butyrylcholinesterase","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111552"}}